Atlas Trials

The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat

Clinical trial NCT04359147 · COMPLETED

Trial details

NCT number
NCT04359147
Sponsor
Charite University, Berlin, Germany
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
YohimbineHydrocortisoneYohimbine + HydrocortisonePlacebo
Start date
2019-11-01
Primary completion
2021-12-22
Enrollment
167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.